TG c.3076_3078delinsTAA ;(p.P1026*)

Variant ID: 8-133909968-CCC-TAA

NM_003235.4(TG):c.3076_3078delinsTAA;(p.P1026*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.

The Journal Of Clinical Investigation
Li, Can C; Xia, Jiliang J; Franqui-Machin, Reinaldo R; Chen, Fangping F; He, Yanjuan Y; Ashby, Timothy Cody TC; Teng, Feixiang F; Xu, Hongwei H; Liu, Dingxiao D; Gai, Dongzheng D; Johnson, Sarah K SK; van Rhee, Frits F; Janz, Siegfried S; Shaughnessy, John D JD; Tricot, Guido G; Frech, Ivana I; Zhan, Fenghuang F
Publication Date: 2021-07-15

Variant appearance in text: TG: p1026x
PubMed Link: 34061780
Variant Present in the following documents:
  • Main text
View BVdb publication page



Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.

Leukemia
Zingone, A A; Cultraro, C M CM; Shin, D-M DM; Bean, C M CM; Morse, H C HC; Janz, S S; Kuehl, W M WM
Publication Date: 2010-06

Variant appearance in text: TG: p1026X
PubMed Link: 20393505
Variant Present in the following documents:
  • Main text
View BVdb publication page